Dashboard
Manage Tickers

SONNSonnet BioTherapeutics Hold...

Nasdaq sonnetbio.com


$ 1.03 $ -0.49 (-32.03 %)    

Thursday, 20-Jun-2024 15:57:25 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 481.70 $ -3.74 (-0.77 %)
DIA $ 392.06 $ 2.93 (0.75 %)
SPY $ 546.68 $ -1.49 (-0.27 %)
TLT $ 93.95 $ -0.63 (-0.67 %)
GLD $ 218.15 $ 2.69 (1.25 %)
$ 1.04
$ 1.12
$ 0.00 x 0
$ 0.00 x 0
$ 1.03 - $ 1.14
$ 1.00 - $ 18.26
432,487
na
5.08M
$ 0.77
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-14-2024 03-31-2024 10-Q
2 02-14-2024 12-31-2023 10-Q
3 12-14-2023 09-30-2023 10-K
4 08-14-2023 06-30-2023 10-Q
5 05-10-2023 03-31-2023 10-Q
6 02-13-2023 12-31-2022 10-Q
7 12-15-2022 09-30-2022 10-K
8 08-15-2022 06-30-2022 10-Q
9 05-10-2022 03-31-2022 10-Q
10 02-08-2022 12-31-2021 10-Q
11 12-17-2021 09-30-2021 10-K
12 08-16-2021 06-30-2021 10-Q
13 05-17-2021 03-31-2021 10-Q
14 02-16-2021 12-31-2020 10-Q
15 12-17-2020 09-30-2020 10-K
16 08-14-2020 06-30-2020 10-Q
17 05-18-2020 03-31-2020 10-Q
18 03-19-2020 12-31-2019 10-K
19 11-14-2019 09-30-2019 10-Q
20 08-14-2019 06-30-2019 10-Q
21 05-15-2019 03-31-2019 10-Q
22 04-01-2019 12-31-2018 10-K
23 11-14-2018 09-30-2018 10-Q
24 08-13-2018 06-30-2018 10-Q
25 05-15-2018 03-31-2018 10-Q
26 03-30-2018 12-31-2017 10-K
27 11-13-2017 09-30-2017 10-Q
28 08-14-2017 06-30-2017 10-Q
29 05-15-2017 03-31-2017 10-Q
30 03-31-2017 12-31-2016 10-K
31 11-10-2016 09-30-2016 10-Q
32 08-11-2016 06-30-2016 10-Q
33 05-16-2016 03-31-2016 10-Q
34 03-31-2016 12-31-2015 10-K
35 11-16-2015 09-30-2015 10-Q
36 08-14-2015 06-30-2015 10-Q
37 05-20-2015 03-31-2015 10-Q
38 04-15-2015 12-31-2014 10-K
39 11-14-2014 09-30-2014 10-Q
40 08-14-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Dow Jumps Over 300 Points; Zapp Electric V...
06/20/2024 18:35:07

why-jabil-shares-are-trading-lower-by-8-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Jabil Shares Are Trading Lower By 8%? ...
06/20/2024 17:26:29

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
06/20/2024 16:32:10

gold-rises-1-accenture-shares-surge-after-q3-results
Gold Rises 1%; Accenture Shares Surge Afte...
06/20/2024 16:00:55

dow-edges-lower-us-current-account-deficit-widens-in-q1
Dow Edges Lower; US Current Account Defici...
06/20/2024 13:42:46

sonnet-biotherapeutics-announces-exercise-of-warrants-for-gross-proceeds-of-34m
Sonnet BioTherapeutics Announces Exercise ...
06/20/2024 12:41:39

sonnet-biotherapeutics-announces-generation-and-in-vitro-characterization-of-novel-drug-candidates-son-1411-and-son-1400
Sonnet BioTherapeutics Announces Generatio...
06/13/2024 12:01:24

Sonnet discovered and characterized a modified version of Interleukin-18 (IL-18Binding Protein Resistant or IL-18BPR) that exhi...

chardan-capital-maintains-buy-on-sonnet-biotherapeutics-maintains-30-price-target
Chardan Capital Maintains Buy on Sonnet Bi...
05/28/2024 10:52:14

Chardan Capital analyst Keay Nakae maintains Sonnet BioTherapeutics (NASDAQ:SONN) with a Buy and maintains $30 price target.

ef-hutton-maintains-buy-on-sonnet-biotherapeutics-lowers-price-target-to-7
EF Hutton Maintains Buy on Sonnet BioThera...
05/16/2024 18:24:33

EF Hutton analyst Tim Moore maintains Sonnet BioTherapeutics (NASDAQ:SONN) with a Buy and lowers the price target from $11 t...

sonnet-biotherapeutics-says-early-safety-data-from-phase-1b2a-clinical-trial-of-son-080-in-chemotherapy-induced-peripheral-neuropathy-met-studys-initial-pre-specified-objective
Sonnet BioTherapeutics Says Early Safety D...
03/11/2024 11:35:29

sonnet-biotherapeutics-reported-son-1010-phase-i-trial-results-demonstrates-safety-efficacy-in-melanoma-model-and-potential-for-dose-escalation
Sonnet BioTherapeutics Reported SON-1010 P...
02/29/2024 21:46:28

sonnet-biotherapeutics-announces-a-publication-demonstrating-safety-and-tolerability-of-son-1010-in-healthy-volunteers
Sonnet BioTherapeutics Announces A Publica...
02/29/2024 21:25:30

Sonnet BioTherapeutics Holdings, Inc., (NASDAQ:SONN) a clinical-stage company developing targeted immunotherapeutic drugs for c...

chardan-capital-maintains-buy-on-sonnet-biotherapeutics-lowers-price-target-to-30
Chardan Capital Maintains Buy on Sonnet Bi...
02/15/2024 17:35:18

Chardan Capital analyst Keay Nakae maintains Sonnet BioTherapeutics (NASDAQ:SONN) with a Buy and lowers the price target fro...

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
02/14/2024 13:05:52

sonnet-biotherapeutics-q1-eps-031-may-not-be-comparable-to-090-estimate-sales-1863k-beat-1800k-estimate
Sonnet BioTherapeutics Q1 EPS $(0.31) May ...
02/14/2024 13:00:09

Sonnet BioTherapeutics (NASDAQ:SONN) reported quarterly losses of $(0.31) per share which beat the analyst consensus estimate o...

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
02/13/2024 21:31:09

sonnet-biotherapeutics-holdings-inc-files-for-mixed-shelf-of-up-to-100m
Sonnet Biotherapeutics Holdings Inc Files ...
12/22/2023 21:38:43

– SEC Filing

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
11/28/2023 21:31:03

ladenburg-thalmann-initiates-coverage-on-sonnet-biotherapeutics-with-buy-rating-announces-price-target-of-7
Ladenburg Thalmann Initiates Coverage On S...
11/27/2023 14:00:47

Ladenburg Thalmann analyst Ahu Demir initiates coverage on Sonnet BioTherapeutics (NASDAQ:SONN) with a Buy rating and announ...

in-october-sonnet-biotherapeutics-completed-public-offering-of-455m-which-is-expected-to-provide-cash-runway-into-q3-2024
In October Sonnet BioTherapeutics Complete...
10/31/2023 11:42:20

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)